A Pharma CDMO case
This analysis illustrates how enterprise-level transformation levers — focused on decision-making, support functions, and coordination mechanisms — translate into tangible financial impact in an asset-intensive CDMO Contract Development and Manufacturing Organization — manufactures complex medicines at industrial scale on behalf of pharmaceutical companies that cannot internalize this level of production complexity. context. This leading player shows a strong operating margin (~29% CORE EBITDA), yet it remains sensitive to operating costs, investment timing, and organizational inefficiencies, which can be materially improved through a targeted transformation programme: in asset-intensive CDMO environments, excessive or mis-scoped transformation is as costly as inaction.
- Primary impact: Selling, General & Administrative expenses and operating overheads
- Secondary impact: asset utilisation and CAPEX efficiency
- Order of magnitude: +3–5% incremental EBITDA (illustrative)
Sample financial data – anonymised CDMO (based on annual financial statements)
| Financial item | FY 2024 (approx.) | Notes |
|---|---|---|
| Revenue | ~CHF 6.6bn | Asset-intensive CDMO model |
| Sales, General & Administration overheads | ~CHF 821m | Corporate and support functions |
| – incl. transformation initiatives | ~CHF 14m | ERP / enterprise transformation programs |
| Other operating expenses | ~CHF 111m | Ad-hoc initiatives, corrective costs |
| CORE EBITDA | ~CHF 1.9bn | ~29% margin |
| Property, plant & equipment (PPE) | ~CHF 8.5bn | Balance sheet – productive assets |
| CAPEX | ~CHF 1.4bn | Cash flow Statement – Purchase of PPE |
What actually moves the P&L
| Transformation lever | P&L line impacted | Impact type |
|---|---|---|
| Process automation | SG&A | Direct |
| Organisational agility | Operating expenses | Cost avoidance |
| Executive insights | EBITDA / ROIC | Structural |
| Data reliability | All lines | Risk reduction |
(Click on each arrow for details)
Process automation – SG&A impact
- Automation of accounting, budgeting, closing and reporting
- Reduced manual effort and rework
- Lower error rates and correction cycles
- Reduced dependency on intermediary coordination layers
Illustrative medium-term impact: 3–8% SG&A reduction
(~CHF 24–65m in an organisation of this scale).
Organisational agility – hidden operating costs
- Fewer ad-hoc corrective initiatives
- Reduced internal misalignment
- Faster arbitration and execution loops
These effects typically materialise in “Other operating expenses”
rather than clearly identifiable efficiency lines.
Executive insights – asset productivity and capital efficiency
- Financial and operational executive dashboards
- Visibility on asset utilisation, ramp-up and bottlenecks
- Integrated cost, capacity and timing perspectives
Decision latency in asset-intensive environments directly translates into under-utilised assets and delayed revenue.
Dedicated management insights protect asset productivity by reducing delays, misalignment and suboptimal capital allocation.
Why asset productivity matters
In asset-intensive CDMO models, asset productivity can be expressed as:
Revenue generated / invested fixed assets
- Faster decisions → earlier revenue generation
- Better CAPEX prioritisation → higher asset turnover
- Improved selectivity → higher ROIC without additional CAPEX
Illustrative order of magnitude of an enterprise-level transformation
- ~5% SG&A reduction → ~CHF 41m
- ~5% operating inefficiencies avoided → ~CHF 6m
- ~1% CAPEX timing & utilisation improvement → ~CHF 14m
Total potential impact: ~CHF 65–80m incremental EBITDA per year
In asset-intensive organisations, value is often lost not through poor execution,
but through slow, misaligned or poorly informed decisions.
Transformation focused on governance, agility and insight primarily reduces
systematic value leakage rather than promising speculative growth.